0001181431-12-021792.txt : 20120403 0001181431-12-021792.hdr.sgml : 20120403 20120403165356 ACCESSION NUMBER: 0001181431-12-021792 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120327 FILED AS OF DATE: 20120403 DATE AS OF CHANGE: 20120403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 161590339 BUSINESS ADDRESS: STREET 1: 1380 WILLOW ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1380 WILLOW ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CORCORAN KEVIN P CENTRAL INDEX KEY: 0001240009 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 12738458 MAIL ADDRESS: STREET 1: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. STREET 2: 1380 WILLOW ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 3 1 rrd340642.xml FORM 3 X0205 3 2012-03-27 0 0001299130 PACIFIC BIOSCIENCES OF CALIFORNIA INC PACB 0001240009 CORCORAN KEVIN P PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 1380 WILLOW ROAD MENLO PARK CA 94025 0 1 0 0 SVP, Market Development Common Stock 8049 D Stock Option (right to buy) 1.96 2017-11-26 Common Stock 112500 D Stock Option (right to buy) 6.96 2018-09-17 Common Stock 37500 D Stock Option (right to buy) 8.5 2020-02-17 Common Stock 50000 D Stock Option (right to buy) 12.74 2020-07-29 Common Stock 12500 D Stock Option (right to buy) 14.24 2021-03-15 Common Stock 150000 D Stock Option (right to buy) 4.79 2022-02-15 Common Stock 250000 D The shares subject to the option are fully vested and exercisable. 1/5th of the shares subject to the option vested on June 1, 2009 and the balance of the shares have vested and will vest monthly thereafter over the next four years, provided that the Reporting Person continues to serve through each vesting date. 1/5th of the shares subject to the option vested on June 1, 2010 and the balance of the shares have vested and will vest monthly thereafter over the next four years, provided that the Reporting Person continues to serve through each vesting date. 1/5th of the shares subject to the option vested on June 1, 2011 and the balance of the shares have vested and will vest monthly thereafter over the next four years, provided that the Reporting Person continues to serve through each vesting date. 1/5th of the shares subject to the option vested on March 15, 2012 and the balance of the shares have vested and will vest monthly thereafter over the next four years, provided that the Reporting Person continues to serve through each vesting date. 1/5th of the shares subject to the option will vest on February 15, 2013 and the balance of the shares will vest monthly thereafter over the next four years, provided that the Reporting Person continues to serve through each vesting date. Brian Dow, Attorney-in-fact for Kevin P. Corcoran 2012-04-03 EX-24. 2 rrd305514_344642.htm POWER OF ATTORNEY rrd305514_344642.html 
					POWER OF ATTORNEY


The undersigned, as a Section 16 reporting person of Pacific Biosciences of California, Inc.
(the "Company"), hereby constitutes and appoints Susan K. Barnes, Brian Dow and Stephen Moore,
and each of them, the undersigned's true and lawful attorney-in-fact to:

1. complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as such
attorney-in-fact shall in his or her discretion determine to be required or advisable pursuant
to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and regulations
promulgated thereunder, or any successor laws and regulations, as a consequence of the
undersigned's ownership, acquisition or disposition of securities of the Company; and

2. do all acts necessary in order to file such forms with the U.S. Securities and Exchange
Commission ("SEC"), any securities exchange or national association, the Company and such other
person or agency as the attorney-in-fact shall deem appropriate.

   The undersigned also hereby constitutes and appoints the responsible attorneys and paralegals
of Wilson Sonsini Goodrich & Rosati P.C., and each of them, the undersigned's true and lawful
attorney-in-fact and agent to complete, execute and file an Update Passphrase Request and the
Update Passphrase Acknowledgement on the Electronic Data Gathering, Analysis, and Retrieval
system ("EDGAR") of the SEC, or such other forms and/or procedures as prescribed by the SEC in
order for the foregoing attorney-in-fact to re-generate the undersigned's SEC EDGAR Filing Codes.

   The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall
do or cause to be done by virtue hereof.  The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16
of the Securities Exchange Act of 1934 (as amended).

   This Power of Attorney shall remain in full force and effect until the undersigned is no
longer required to file Forms ID, 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the undersigned in
a signed writing delivered to the Company and the foregoing attorneys-in-fact.

   IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of
this 27th day of March, 2012.


Signature: /s/ Kevin P. Corcoran
Name:	Kevin P. Corcoran